Close Menu

NEW YORK ─ Siemens Healthineers on Wednesday said that it has obtained the CE mark for a quantitative SARS-CoV-2 IgG antibody test, enabling its use in Europe and other regions that accept the designation.

The Erlangen, Germany-based firm said it has also applied to the US Food and Drug Administration for Emergency Use Authorization.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.